Tag Archives: blastic plasmacytoid dendritic cell neoplasm

December, 2018

November, 2017

September, 2017

February, 2017

  • 8 February

    Cellectis Gains FDA Approval to Test New Gene Edited CAR T-Cell Therapy

    NEW YORK–(BUSINESS WIRE)–Regulatory News: Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Alternext: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells (UCART), has received an Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) to conduct Phase 1 clinical trials with UCART123, the Company’s …